The prevalence of autoimmune disease in patients with esophageal achalasia

Diseases of the Esophagus

Volumn 25, Issue 3, 2012, Pages 209-213

  Booy, J D ^a   Takata, J ^a   Tomlinson, G ^a   Urbach, D R ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoimmune disease; Epidemiology; Esophageal achalasia; Etiology

Indexed keywords

ADOLESCENT; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESOPHAGUS ACHALASIA; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEITIS;

ADULT; AGE FACTORS; AUTOIMMUNE DISEASES; CANADA; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ESOPHAGEAL ACHALASIA; FEMALE; HUMANS; HYPOTHYROIDISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; UVEITIS;

EID: 84859637829     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01249.x     Document Type: Article

References (16)

1. Williams V A, Peters J H. Achalasia of the esophagus: a surgical disease. J Am Coll Surg 2009; 208: 151-62.
2. Park W, Vaezi M F. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005; 100: 1404-14.
3. Bruley des Varannes S, Chevalier J, Pimont S etal. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 2006; 55: 319-26.
4. Moses P L, Ellis L M, Anees M R etal. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003; 52: 629-36.
5. Rose N R, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426-30.
6. Hidalgo-Tenorio C, Sabio J M, Jaimez L, Jimenez-Alonso J. Achalasia, angioedema and systemic lupus erythematosus. Lupus 2001; 10: 831-2.
7. Kornizky Y, Heller I, Isakov A, Shapira I, Topilsky M. Dysphagia with multiple autoimmune disease. Clin Rheumatol 2000; 19: 321-3.
8. Emami M H, Raisi M, Amini J, Daghaghzadeh H. Achalasia and thyroid disease. World J Gastroenterol 2007; 13: 594-9.
9. Jacobson D L, Gange S J, Rose N R, Graham N M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
10. Carter E T, McKenna C H, Brian D D, Kurland L T. Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973. Arthritis Rheum 1979; 22: 365-70.
11. Fasano A, Berti I, Gerarduzzi T etal. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
12. Wilson E B. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927; 22: 209-12.
13. Burt V L, Whelton P, Roccella E J etal. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.
14. Lloyd-Jones D, Adams R J, Brown T M etal., American Heart Association Statistics Committee and Stroke Statistics, Subcommittee. Heart disease and stroke statistics - 2010 update. Circulation 2010; 121: 948-54.
15. Mannino D M, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 502-6.
16. Snow V, Weiss K B, LeFevre M etal., AAFP Panel on Atrial F, ACP Panel on Atrial F. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003; 139: 1009-17.